NDUFB2-AS1

Across TCGA pan-cancer cohorts, NDUFB2-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated NDUFB2-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NDUFB2-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NDUFB2-AS1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

KIRC, ACC, and HNSC are the cancer types where NDUFB2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.529	0.711	<.001	177	view →
ACC	DFS	Tertile	All	0.277	0.723	<.001	69	view →
HNSC	DFS	Median	II,III,IV	0.735	0.632	.003	67	view →
KICH	DFS	Quartile	III,IV	0.192	1.000	.002	66	view →
LGG	OS	Median	All	0.737	0.876	<.001	52	view →
LIHC	DFS	Tertile	All	0.443	0.595	.002	51	view →
COAD	OS	Quartile	All	0.708	0.918	.002	47	view →
ESCA	DFS	Median	IV	0.634	0.205	.006	24	view →
PRAD	DFS	Median	All	0.836	0.932	<.001	24	view →
LUSC	DFS	Quartile	II,III,IV	0.811	0.589	.004	22	view →
READ	OS	Median	III,IV	0.836	0.430	.018	21	view →
PAAD	DFS	Quartile	All	0.421	0.168	.007	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

NDUFB2-AS1–KIRC (OS)

Open the KIRC breakdown →